Total Payments
$10,820
2024 Payments
$4,285
Companies
55
Transactions
471
Medicare Patients
1,061
Medicare Billing
$128,317
Payment Breakdown by Category
Food & Beverage$9,897 (91.5%)
Other$681.53 (6.3%)
Education$241.16 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,897 | 455 | 91.5% |
| Long term medical supply or device loan | $681.53 | 7 | 6.3% |
| Education | $241.16 | 9 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,727 | 68 | $0 (2024) |
| Merck Sharp & Dohme LLC | $821.36 | 34 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $804.97 | 40 | $0 (2024) |
| PFIZER INC. | $655.04 | 37 | $0 (2024) |
| Lilly USA, LLC | $605.80 | 20 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $559.05 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $499.10 | 20 | $0 (2024) |
| Astellas Pharma US Inc | $354.90 | 16 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $280.66 | 11 | $0 (2024) |
| Daiichi Sankyo Inc. | $260.54 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,285 | 158 | Novartis Pharmaceuticals Corporation ($805.98) |
| 2023 | $3,890 | 150 | Myriad Genetic Laboratories, Inc. ($410.80) |
| 2022 | $91.89 | 4 | Lilly USA, LLC ($30.15) |
| 2021 | $19.82 | 1 | Amgen Inc. ($19.82) |
| 2019 | $36.97 | 1 | PFIZER INC. ($36.97) |
| 2018 | $1,158 | 69 | Novartis Pharmaceuticals Corporation ($246.98) |
| 2017 | $1,338 | 88 | Novartis Pharmaceuticals Corporation ($289.13) |
All Payment Transactions
471 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.28 | General |
| 12/16/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $29.66 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $30.50 | General |
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $25.31 | General |
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $2.53 | General |
| 12/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $32.08 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Oncology | ||||||
| 12/03/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/02/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $26.66 | General |
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Oncology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: NONE | ||||||
| 11/07/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $46.25 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 11/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Rare Disease | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: HEMATOLOGY | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $25.28 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 562 | 14,132 | $230,959 | $54,206 |
| 2022 | 4 | 79 | 111 | $16,222 | $4,567 |
| 2021 | 3 | 106 | 195 | $61,259 | $17,587 |
| 2020 | 3 | 314 | 502 | $171,351 | $51,957 |
Total Patients
1,061
Total Services
14,940
Medicare Billing
$128,317
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 99 | $33,561 | $9,200 | 27.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 65 | $30,810 | $8,622 | 28.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 38 | 42 | $23,352 | $5,763 | 24.7% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 14 | 12,750 | $51,000 | $4,990 | 9.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 12 | 41 | $15,498 | $3,773 | 24.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $11,325 | $3,134 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 46 | $10,994 | $3,095 | 28.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 95 | 344 | $3,096 | $2,890 | 93.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 24 | 49 | $9,261 | $2,380 | 25.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 90 | 312 | $9,048 | $2,359 | 26.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 37 | $7,289 | $2,316 | 31.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $8,190 | $2,028 | 24.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 111 | $7,659 | $1,151 | 15.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,278 | $968.22 | 29.5% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 11 | 37 | $3,108 | $810.72 | 26.1% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 19 | 41 | $2,501 | $483.03 | 19.3% |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | Office | 2023 | 17 | 29 | $319.00 | $93.16 | 29.2% |
| 85046 | Red blood count automated, with additional calculations | Office | 2023 | 14 | 14 | $280.00 | $76.44 | 27.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 65 | $390.00 | $73.10 | 18.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 17 | $9,452 | $2,657 | 28.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 19 | $5,415 | $1,531 | 28.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 25 | 34 | $986.00 | $258.74 | 26.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 27 | 41 | $369.00 | $120.54 | 32.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 46 | 49 | $26,295 | $7,250 | 27.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 29 | 86 | $23,564 | $6,974 | 29.6% |
About Dr. Monique Sajjad, DO
Dr. Monique Sajjad, DO is a Hematology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2010. The National Provider Identifier (NPI) number assigned to this provider is 1487973087.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Monique Sajjad, DO has received a total of $10,820 in payments from pharmaceutical and medical device companies, with $4,285 received in 2024. These payments were reported across 471 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($9,897).
As a Medicare-enrolled provider, Sajjad has provided services to 1,061 Medicare beneficiaries, totaling 14,940 services with total Medicare billing of $128,317. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Medical Oncology
- Location Tampa, FL
- Active Since 05/20/2010
- Last Updated 09/01/2022
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1487973087
Products in Payments
- KISQALI (Drug) $766.14
- KEYTRUDA (Biological) $681.16
- OPDIVO (Biological) $622.19
- VERZENIO (Drug) $511.41
- MYRISK (Device) $409.00
- Enhertu (Drug) $234.19
- IMFINZI (Biological) $232.99
- IMBRUVICA (Drug) $232.66
- ELIQUIS (Drug) $220.87
- SARCLISA (Biological) $215.64
- LIBTAYO (Biological) $179.38
- Lenvima (Drug) $173.97
- TASIGNA (Drug) $166.37
- Rezlidhia (Drug) $163.75
- ULTOMIRIS (Biological) $162.06
- ALUNBRIG (Drug) $154.59
- JAKAFI (Drug) $150.97
- PRECISETUMOR (Device) $150.05
- IBRANCE (Drug) $148.03
- INLYTA (Drug) $146.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Tampa
Rami Komrokji, M.d, M.D
Hematology — Payments: $850,782
Hematology $850,782
Dr. Julia Cogburn, M.d, M.D
Hematology — Payments: $133,076
Hematology $133,076
Dr. Robert Weaver, Md, MD
Hematology — Payments: $110,649
Hematology $110,649
Alan List, Md, MD
Hematology — Payments: $94,305
Hematology $94,305
Dr. David Wright, Md, MD
Hematology — Payments: $82,377
Hematology $82,377
Lubomir Sokol, Md, MD
Hematology — Payments: $27,903
Hematology $27,903